Chemical contamination: emission of strong odor after package was opened.
All Recalls
95,123 total recalls in our database
Discoloration; Product may not meet specifications for color description once reconstituted.
Non-Sterility: One confirmed customer report that product contained spore-like particulates, consistent with mold.
Chemical contamination: emission of strong odor after package was opened.
Chemical contamination: emission of strong odor after package was opened..
Presence of Foreign Substance: Product is being recalled due to receiving an elevated number of patient complaints related to a visible presence of medical grade silicone oil essential to the functionality of the syringe and plunger stopper system.
Actra-SX 500 Capsules, Maximum Strength, Energizer, 500 mg, 5 count package, Body Basics, Canoga Park, CA
Body Basics
Marketed without an Approved NDA/ANDA; product contains sildenafil, an active ingredient in a FDA approved product for the treatment of Erectile Dysfunction
Marketed without an Approved NDA/ANDA; product found to contain sulfoaildenafil, an analogue of sildenafil, the active ingredient in a FDA approved product used for erectile dysfunction, making it an unapproved new drug
Labeling: Not Elsewhere Classified: This unit dose product is being recalled because the product's name includes the word "Children's" which is misleading since the 650 mg dose of acetaminophen contained within it, is an adult dose.
Chemical contamination: emission of strong odor after package was opened
Chemical contamination: emission of strong odor after package was opened..
Chemical contamination: emission of strong odor after package was opened..
Chemical contamination: emission of strong odor after package was opened.
Chemical contamination: emission of strong odor after package was opened.
Chemical contamination: emission of strong odor after package was opened.
Chemical contamination: emission of strong odor after package was opened.
Chemical contamination: emission of strong odor after package was opened.
Failed USP Dissolution Test Requirements: Out-of-specification dissolution results at the 8 hour stability testing point.
Non-Sterility: Confirmed customer complaint of product contaminated with mold.
EsophyX2Plus device was not validated under actual or simulated use conditions prior to distributing the product to physicians.